PowerBacGWAS: a computational pipeline to perform power calculations for bacterial genome-wide association studies DOI Creative Commons
Francesc Coll, Theodore Gouliouris, Sebastian Bruchmann

et al.

Communications Biology, Journal Year: 2022, Volume and Issue: 5(1)

Published: March 25, 2022

Genome-wide association studies (GWAS) are increasingly being applied to investigate the genetic basis of bacterial traits. However, approaches perform power calculations for GWAS limited. Here we implemented two alternative conduct using existing collections genomes. First, a sub-sampling approach was undertaken reduce allele frequency and effect size known detectable genotype-phenotype relationship by modifying phenotype labels. Second, phenotype-simulation conducted simulate phenotypes from variants. We both into computational pipeline (PowerBacGWAS) that supports burden testing, pan-genome variant GWAS; it Enterococcus faecium, Klebsiella pneumoniae Mycobacterium tuberculosis. used this determine sample sizes required detect causal variants different minor frequencies (MAF), heritability, studied homoplasy population diversity on Our user documentation made available can be other populations. PowerBacGWAS find statistically significant associations, or associations with given size. recommend genomes species study.

Language: Английский

BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking DOI Creative Commons
Ye Feng,

Shengmei Zou,

Hangfei Chen

et al.

Nucleic Acids Research, Journal Year: 2020, Volume and Issue: 49(D1), P. D644 - D650

Published: Sept. 17, 2020

Abstract An increasing prevalence of hospital acquired infections and foodborne illnesses caused by pathogenic multidrug-resistant bacteria has stimulated a pressing need for benchtop computational techniques to rapidly accurately classify from genomic sequence data, based on that, trace the source infection. BacWGSTdb (http://bacdb.org/BacWGSTdb) is free publicly accessible database we have developed bacterial whole-genome typing tracking. This incorporates extensive resources genome sequencing data corresponding metadata, combined with specialized bioinformatics tools that enable systematic characterization isolates recovered infections. Here, present 2.0, which encompasses several major updates, including (i) integration core multi-locus (cgMLST) approach, highly scalable appropriate belonging different lineages; (ii) addition multiple analysis module can process dozens user uploaded sequences in batch mode; (iii) new tracking comparing plasmid those deposited public databases; (iv) number species encompassed 2.0 increased 9 20, represents pathogens medical importance; (v) newly designed, user-friendly interface set visualization providing convenient platform users are also included. Overall, updated bears great utility continuing provide users, epidemiologists, clinicians bench scientists, one-stop solution analysis.

Language: Английский

Citations

164

Applications of Machine Learning to the Problem of Antimicrobial Resistance: an Emerging Model for Translational Research DOI
Melis N. Anahtar, Jason H. Yang, Sanjat Kanjilal

et al.

Journal of Clinical Microbiology, Journal Year: 2021, Volume and Issue: 59(7)

Published: Jan. 29, 2021

Antimicrobial resistance (AMR) remains one of the most challenging phenomena modern medicine. Machine learning (ML) is a subfield artificial intelligence that focuses on development algorithms learn how to accurately predict outcome variables using large sets predictor are typically not hand selected and minimally curated.

Language: Английский

Citations

144

Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy DOI Creative Commons
Ekaterina Avershina,

Valeria Shapovalova,

German A. Shipulin

et al.

Frontiers in Microbiology, Journal Year: 2021, Volume and Issue: 12

Published: July 21, 2021

Rising antibiotic resistance is a global threat that projected to cause more deaths than all cancers combined by 2050. In this review, we set summarize the current state of resistance, and give an overview emerging technologies aimed escape pre-antibiotic era recurrence. We conducted comprehensive literature survey >150 original research review articles indexed in Web Science using “antimicrobial resistance,” “diagnostics,” “therapeutics,” “disinfection,” “nosocomial infections,” “ESKAPE pathogens” as key words. discuss impact nosocomial infections on spread multi-drug resistant bacteria, over existing developing strategies for faster diagnostics infectious diseases, novel approaches therapy finally hospital disinfection prevent MDR bacteria spread.

Language: Английский

Citations

109

Genomics and pathotypes of the many faces ofEscherichia coli DOI Creative Commons
Jeroen Geurtsen,

Mark de Been,

Eveline Weerdenburg

et al.

FEMS Microbiology Reviews, Journal Year: 2022, Volume and Issue: 46(6)

Published: June 24, 2022

Escherichia coli is the most researched microbial organism in world. Its varied impact on human health, consisting of commensalism, gastrointestinal disease, or extraintestinal pathologies, has generated a separation species into at least eleven pathotypes (also known as pathovars). These are broadly split two groups, intestinal pathogenic E. (InPEC) and (ExPEC). However, components coli's infinite open accessory genome horizontally transferred with substantial frequency, creating hybrid strains that defy clear pathotype designation. Here, we take birds-eye view species, characterizing it from historical, clinical, genetic perspectives. We examine wide spectrum disease caused by coli, content bacterium, its propensity to acquire, exchange, maintain antibiotic resistance genes virulence traits. Our portrayal also discusses elements have shaped overall population structure summarizes current state vaccine development targeted frequent pathovars. In our conclusions, advocate streamlining efforts for clinical reporting ExPEC, emphasize potential exists throughout entire species.

Language: Английский

Citations

102

Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective DOI
Jee In Kim, Finlay Maguire, Kara K. Tsang

et al.

Clinical Microbiology Reviews, Journal Year: 2022, Volume and Issue: 35(3)

Published: May 25, 2022

Antimicrobial resistance (AMR) is a global health crisis that poses great threat to modern medicine. Effective prevention strategies are urgently required slow the emergence and further dissemination of AMR. Given availability data sets encompassing hundreds or thousands pathogen genomes, machine learning (ML) increasingly being used predict different antibiotics in pathogens based on gene content genome composition. A key objective this work advocate for incorporation ML into front-line settings but also highlight refinements necessary safely confidently incorporate these methods. The question what not trivial given existence quantitative qualitative laboratory measures models typically treat genes as independent predictors, with no consideration structural functional linkages; they may be accurate when new mutational variants known AMR emerge. Finally, have technology trusted by end users public settings, need transparent explainable ensure basis prediction clear. We strongly next set AMR-ML studies should focus refinement limitations able bridge gap diagnostic implementation.

Language: Английский

Citations

94

Antimicrobial resistance crisis: could artificial intelligence be the solution? DOI Creative Commons
Guangyu Liu, Dan Yu,

Mei-Mei Fan

et al.

Military Medical Research, Journal Year: 2024, Volume and Issue: 11(1)

Published: Jan. 23, 2024

Abstract Antimicrobial resistance is a global public health threat, and the World Health Organization (WHO) has announced priority list of most threatening pathogens against which novel antibiotics need to be developed. The discovery introduction are time-consuming expensive. According WHO’s report antibacterial agents in clinical development, only 18 have been approved since 2014. Therefore, critically needed. Artificial intelligence (AI) rapidly applied drug development its recent technical breakthrough dramatically improved efficiency antibiotics. Here, we first summarized recently marketed antibiotics, antibiotic candidates development. In addition, systematically reviewed involvement AI utilization, including small molecules, antimicrobial peptides, phage therapy, essential oils, as well mechanism prediction, stewardship.

Language: Английский

Citations

40

Multidrug-resistant Gram-negative bacterial infections DOI
Nenad Macesic, Anne‐Catrin Uhlemann, Anton Y. Peleg

et al.

The Lancet, Journal Year: 2025, Volume and Issue: 405(10474), P. 257 - 272

Published: Jan. 1, 2025

Language: Английский

Citations

7

Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases DOI
Sheng He, Leon G. Leanse, Yanfang Feng

et al.

Advanced Drug Delivery Reviews, Journal Year: 2021, Volume and Issue: 178, P. 113922 - 113922

Published: Aug. 28, 2021

Language: Английский

Citations

80

Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation DOI
Jiaxin Yu, Yu-Tzu Lin, Wei-Cheng Chen

et al.

International Journal of Antimicrobial Agents, Journal Year: 2023, Volume and Issue: 61(6), P. 106799 - 106799

Published: March 31, 2023

Language: Английский

Citations

23

Revisiting therapeutic options against Resistant Klebsiella Pneumoniae infection: phage therapy is key DOI
Jiabao Xing,

Rong-jia Han,

Jinxin Zhao

et al.

Microbiological Research, Journal Year: 2025, Volume and Issue: unknown, P. 128083 - 128083

Published: Jan. 1, 2025

Language: Английский

Citations

1